Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

Detalles Bibliográficos
Autores principales: Yang, Yin, Wang, Jianyang, Wang, Wenqing, Zhang, Tao, Zhao, Jingjing, Wang, Yu, Li, Yexiong, Wang, Luhua, Bi, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462661/
https://www.ncbi.nlm.nih.gov/pubmed/36091135
http://dx.doi.org/10.3389/fonc.2022.1007862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462661/
https://www.ncbi.nlm.nih.gov/pubmed/36091135
http://dx.doi.org/10.3389/fonc.2022.1007862

Ejemplares similares